» Articles » PMID: 34297178

Progressive Cortical and Sub-cortical Alterations in Patients with Anti-N-methyl-D-aspartate Receptor Encephalitis

Overview
Journal J Neurol
Specialty Neurology
Date 2021 Jul 23
PMID 34297178
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Advanced structural analyses are increasingly being highly valued to uncover pathophysiological understanding of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Therefore, we aimed to explore whether and how antibody-mediated NMDAR dysfunction affected cortical and sub-cortical brain morphology and their relationship with clinical symptoms.

Methods: We performed surface-based morphometry analyses, hippocampal segmentation, and correlational analyses in 24 patients with anti-NMDAR encephalitis after acute disease stage and 30 normal controls (NC) in this case-control study.

Results: Patients showed significantly decreased cortical alterations mainly in language network (LN) and default mode network (DMN), as well as decreased gray matter volume in left cornu ammonis 1 (CA1) body of hippocampus. Further correlation analyses showed that the decreased cortical thickness in the right superior frontier gyrus was associated with decreased cognitive scores, the decreased cortical volume in the right pars triangulari and decreased surface area in the right pars operculari were associated with decreased memory scores, whereas decreased gray matter volume in the left CA1 body was significantly correlated with longer time between first symptom and imaging in the patients.

Conclusion: These results suggested that cognitive impairments resulted from long-term sequelae of the encephalitis were mainly associated with cortical alterations in LN and DMN and sub-cortical atrophy of left CA1 body, which can be served as effective features to assess disease progression in clinical routine examination.

Citing Articles

Abnormal large-scale resting-state functional networks in anti-N-methyl-D-aspartate receptor encephalitis.

Gong X, Wang L, Guo Y, Ma Y, Li W, Zhang J Front Neurosci. 2024; 18:1455131.

PMID: 39224578 PMC: 11366611. DOI: 10.3389/fnins.2024.1455131.


Aberrant functional hubs and related networks attributed to cognitive impairment in patients with anti‑N‑methyl‑D‑aspartate receptor encephalitis.

Fan B, Zhou X, Pang L, Long Q, Lv C, Zheng J Biomed Rep. 2024; 21(1):104.

PMID: 38827495 PMC: 11140295. DOI: 10.3892/br.2024.1792.


Functional connectivity changes of the hippocampal subregions in anti-N-methyl-D-aspartate receptor encephalitis.

Yang Y, Fu S, Jiang G, Xu G, Tian J, Ma X Brain Imaging Behav. 2024; 18(3):686-697.

PMID: 38363500 DOI: 10.1007/s11682-024-00852-3.


Language impairments in seropositive and seronegative autoimmune encephalitis.

Griffith S, Wesselingh R, DAprano F, Seery N, Rushen T, Kyndt C Neurol Sci. 2024; 45(7):3389-3398.

PMID: 38358549 PMC: 11176237. DOI: 10.1007/s10072-024-07382-2.


Neural Surface Antibodies and Neurodegeneration: Clinical Commonalities and Pathophysiological Relationships.

Giannoccaro M, Verde F, Morelli L, Rizzo G, Ricciardiello F, Liguori R Biomedicines. 2023; 11(3).

PMID: 36979644 PMC: 10045131. DOI: 10.3390/biomedicines11030666.


References
1.
Graus F, Titulaer M, Balu R, Benseler S, Bien C, Cellucci T . A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016; 15(4):391-404. PMC: 5066574. DOI: 10.1016/S1474-4422(15)00401-9. View

2.
Deakin J, Lennox B, Zandi M . Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis. Biol Psychiatry. 2013; 75(4):284-91. DOI: 10.1016/j.biopsych.2013.07.018. View

3.
de Bruijn M, Aarsen F, van Oosterhout M, van der Knoop M, Catsman-Berrevoets C, Schreurs M . Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis. Neurology. 2018; 90(22):e1997-e2005. PMC: 5980521. DOI: 10.1212/WNL.0000000000005605. View

4.
McKeon G, Robinson G, Ryan A, Blum S, Gillis D, Finke C . Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: A systematic review. J Clin Exp Neuropsychol. 2017; 40(3):234-252. DOI: 10.1080/13803395.2017.1329408. View

5.
Zhang T, Duan Y, Ye J, Xu W, Shu N, Wang C . Brain MRI Characteristics of Patients with Anti--Methyl-D-Aspartate Receptor Encephalitis and Their Associations with 2-Year Clinical Outcome. AJNR Am J Neuroradiol. 2018; 39(5):824-829. PMC: 7410660. DOI: 10.3174/ajnr.A5593. View